Clinical trial
A Controlled, Randomized, Within-subject, Multi-center Prospective Clinical Trial of DA-13-007 (Injectable Poly-L-lactic Acid) Versus SCULPTRA® Aesthetic (Injectable Poly-L-lactic Acid) in the Treatment of Nasolabial Fold Wrinkles.
NCT02310490 is registered in ClinicalTrials.gov with DermAvance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Controlled, Randomized, Within-subject, Multi-center Prospective Clinical Trial of DA-13-007 (Injectable Poly-L-lactic Acid) Versus SCULPTRA® Aesthetic (Injectable Poly-L-lactic Acid) in the Treatment of Nasolabial Fold Wrinkles.
- Lead sponsor
- DermAvance
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- December 31, 2018
- Enrollment
- 161 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
face; atrophy